Plasmacytoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials
• Forums

a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients
Conditions:   Multiple Myeloma;   Plasma Cell Leukemia;   Extramedullary Plasmacytoma;   Loss of Chromosome 17p;   t(14;16);   t(4;14);   T(14;20);   1Q21 Amplification;   Complex Karyotype Interventions:   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Procedure: Autologous Hematopoietic Stem Cell Transplantation x 1 or x 2;   Drug: Melphalan Given IV;   Drug: Fludarabine Injection;   Drug: PI and dexamethasone as maintenance therapy;   Drug: PI+IMids+Dexamethason e as Consolidated Chemotherapy Sponsor:   Institute of Hematology & Blood Diseases Hospital Recruiti...
Source: ClinicalTrials.gov - July 4, 2019 Category: Research Source Type: clinical trials